Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet Income
Growth Metrics
Income Statement
Others
Ratios

Exousia Bio (LMMY) Net Cash Flow (2022 - 2025)

Lamy (LMMY) has disclosed Net Cash Flow for 4 consecutive years, with -$1.0 as the latest value for Q4 2025.

  • Quarterly Net Cash Flow changed N/A to -$1.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1029.0 through Nov 2025, changed N/A year-over-year, with the annual reading at -$1028.0 for FY2025, 84.94% up from the prior year.
  • Net Cash Flow hit -$1.0 in Q4 2025 for Lamy, up from -$1028.0 in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $3691.0 in Q2 2023 to a low of -$8321.0 in Q3 2022.
  • Historically, Net Cash Flow has averaged -$1010.8 across 4 years, with a median of -$146.0 in 2023.
  • Biggest five-year swings in Net Cash Flow: surged 33.33% in 2023 and later tumbled 51300.0% in 2025.
  • Year by year, Net Cash Flow stood at -$435.0 in 2022, then skyrocketed by 33.33% to -$290.0 in 2023, then skyrocketed by 100.69% to $2.0 in 2024, then tumbled by 150.0% to -$1.0 in 2025.
  • Business Quant data shows Net Cash Flow for LMMY at -$1.0 in Q4 2025, -$1028.0 in Q1 2025, and $2.0 in Q2 2024.